• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

κ阿片受体拮抗作用对肥胖型 Zucker 大鼠能量消耗的影响。

The effect of kappa opioid receptor antagonism on energy expenditure in the obese Zucker rat.

作者信息

Jarosz Patricia A

机构信息

Wayne State University, College of Nursing, Detroit, Michigan 48202, USA.

出版信息

Biol Res Nurs. 2007 Apr;8(4):294-9. doi: 10.1177/1099800406298774.

DOI:10.1177/1099800406298774
PMID:17456590
Abstract

Food intake and, subsequently, body weight are influenced by endogenous opioids acting in the central nervous system. Agonists for the opioid receptor increase food intake, whereas antagonists reduce food intake. Body weight, however, is the result of food consumed and energy expended. Although much has been reported about the effect of opioid antagonism on food intake, less has been reported about its effect on energy expended. This study investigated the effect of selective antagonism of the kappa opioid receptor on food intake, body weight, and indicators of energy expenditure in male obese Zucker rats (n=10). Energy expenditure was measured by indirect calorimetry, whereas general activity and body temperature were measured by implanted radio frequency telemetry. Central administration of 30 microg of the kappa opioid receptor (KOR) antagonist norbinaltorphamine resulted in a significant 34% reduction in food intake (p =.001), a small reduction in body weight, a reduction in resting energy expenditure (p = .06), a reduction in respiratory quotient (p =.06), a 14% reduction in general activity, and a reduction in core body temperature. Reduction in body weight as a result of KOR inhibition in this study was related to a decrease in food intake but not related to an increase in energy expended or activity.

摘要

食物摄入量以及随后的体重受到作用于中枢神经系统的内源性阿片类物质的影响。阿片受体激动剂会增加食物摄入量,而拮抗剂则会减少食物摄入量。然而,体重是所摄入食物和消耗能量的结果。尽管关于阿片类拮抗剂对食物摄入量的影响已有大量报道,但关于其对能量消耗的影响报道较少。本研究调查了选择性拮抗κ阿片受体对雄性肥胖Zucker大鼠(n = 10)的食物摄入量、体重和能量消耗指标的影响。通过间接测热法测量能量消耗,而通过植入式射频遥测技术测量一般活动和体温。向中枢给予30微克的κ阿片受体(KOR)拮抗剂诺美沙朵,导致食物摄入量显著减少34%(p = .001),体重略有下降,静息能量消耗减少(p = .06),呼吸商降低(p = .06),一般活动减少14%,以及核心体温降低。在本研究中,由于KOR抑制导致的体重减轻与食物摄入量减少有关,但与能量消耗增加或活动增加无关。

相似文献

1
The effect of kappa opioid receptor antagonism on energy expenditure in the obese Zucker rat.κ阿片受体拮抗作用对肥胖型 Zucker 大鼠能量消耗的影响。
Biol Res Nurs. 2007 Apr;8(4):294-9. doi: 10.1177/1099800406298774.
2
The effect of opioid antagonism on food intake behavior and body weight in a biobehavioral model of obese binge eating.阿片类拮抗剂对肥胖暴饮暴食生物行为模型中食物摄入行为和体重的影响。
Biol Res Nurs. 2002 Apr;3(4):198-209. doi: 10.1177/10900402003004005.
3
Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats.中枢黑皮质素系统调节肥胖和瘦素 Zucker 大鼠的能量摄入与消耗。
Am J Physiol Regul Integr Comp Physiol. 2001 Aug;281(2):R444-51. doi: 10.1152/ajpregu.2001.281.2.R444.
4
Peptides that regulate food intake: antagonism of opioid receptors reduces body fat in obese rats by decreasing food intake and stimulating lipid utilization.调节食物摄入的肽:阿片受体拮抗剂通过减少食物摄入和刺激脂质利用来降低肥胖大鼠的体脂。
Am J Physiol Regul Integr Comp Physiol. 2003 Jun;284(6):R1399-408. doi: 10.1152/ajpregu.00632.2002.
5
Opioid regulation of food intake and body weight in humans.阿片类物质对人类食物摄入和体重的调节作用
Fed Proc. 1987 Jan;46(1):178-82.
6
Evaluation of chronic opioid receptor antagonist effects upon weight and intake measures in lean and obese Zucker rats.评估慢性阿片受体拮抗剂对瘦型和肥胖型 Zucker 大鼠体重及摄入量指标的影响。
Peptides. 1997;18(8):1201-7. doi: 10.1016/s0196-9781(97)00074-0.
7
Combined blockade of both micro - and kappa-opioid receptors prevents the acute orexigenic action of Agouti-related protein.对微阿片受体和κ阿片受体的联合阻断可防止刺鼠相关蛋白的急性促食欲作用。
Endocrinology. 2002 Nov;143(11):4265-70. doi: 10.1210/en.2002-220230.
8
Nalmefene decreases meal size, food and water intake and weight gain in Zucker rats.纳美芬可减少肥胖 Zucker 大鼠的进食量、食物和水摄入量以及体重增加。
Pharmacol Biochem Behav. 1983 Aug;19(2):235-40. doi: 10.1016/0091-3057(83)90045-x.
9
Adjustments in daily energy expenditure to caloric restriction and weight loss by adult obese and lean Zucker rats.成年肥胖和瘦型 Zucker 大鼠对热量限制和体重减轻的每日能量消耗调整。
Int J Obes. 1990 Dec;14(12):1079-84.
10
Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats.在大鼠饮食性肥胖发展过程中,长期使用中枢阿片受体亚型拮抗剂后体重的减轻。
Brain Res. 1995 Apr 24;678(1-2):168-76. doi: 10.1016/0006-8993(95)00181-o.

引用本文的文献

1
Activation of Kappa Opioid Receptor Regulates the Hypothermic Response to Calorie Restriction and Limits Body Weight Loss.κ 阿片受体的激活调节热量限制引起的体温降低反应并限制体重下降。
Curr Biol. 2019 Dec 16;29(24):4291-4299.e4. doi: 10.1016/j.cub.2019.10.027. Epub 2019 Nov 27.
2
Genes and biochemical pathways in human skeletal muscle affecting resting energy expenditure and fuel partitioning.影响静息能量消耗和燃料分配的人类骨骼肌中的基因和生化途径。
J Appl Physiol (1985). 2011 Mar;110(3):746-55. doi: 10.1152/japplphysiol.00293.2010. Epub 2010 Nov 25.
3
Sex differences in kappa opioid pharmacology.
κ 阿片受体药理学的性别差异。
Life Sci. 2011 Jan 3;88(1-2):2-16. doi: 10.1016/j.lfs.2010.10.007. Epub 2010 Oct 14.
4
Analogues of (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic). Synthesis and in vitro and in vivo opioid receptor antagonist activity.(3R)-7-羟基-N-[(1S)-1-{(3R,4R)-4-(3-羟基苯基)-3,4-二甲基-1-哌啶基甲基}-2-甲基丙基]-1,2,3,4-四氢-3-异喹啉甲酰胺(JDTic)类似物。合成及体外和体内阿片受体拮抗剂活性。
J Med Chem. 2010 Jul 22;53(14):5290-301. doi: 10.1021/jm1004978.